Clinical Trial Update: Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing stress-dose hydrocortisone for coagulation dysfunction in septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: Nanjing PLA General Hospital | Conditions: Septic Shock, Sepsis | Phase 3 | Status: COMPLETED